Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Apollo Hospitals 6...

    Apollo Hospitals 6 percent stake sold for Rs 1,070 crore

    Written by savita thakur thakur Published On 2017-03-05T11:11:57+05:30  |  Updated On 18 Aug 2021 12:13 PM IST
    Apollo Hospitals 6 percent stake sold for Rs 1,070 crore

    IHH Healthcare Berhad, Asia's largest private healthcare group has reportedly sold six percent stake of it in Apollo Hospitals Enterprise for Rs 1,070 crore ($160 million). According to the media reports, IHH is primarily focusing to run its own Hospital business in India.


    TOI reports that IHH Mauritius has sold the around 84.4 lakh shares of Apollo in the price range of Rs 1,267-Rs 1,320 per share in bulk deals.


    Till the end of the December 2016, IHH held around 10.85 per cent equity share in Apollo Hospitals Enterprise Ltd. It is expected that this exit from the Apollo Hospitals will help the IHH to build its own hospital business in India. It has acquired around 73.4 per cent stake in Global Hospitals in August 2015, for 195 million dollars.


    A Krishnan, Chief financial officer of Apollo Hospitals told TOI, "IHH had informed us of their intention to sell. Today we hear that they have offloaded nearly 6% through secondary market sales. While we are not aware who the buyers are, we believe that some FIIs and DIIs including MFs could have picked the shares up."


    IHH owns Singapore-based Parkway Pantai, the largest private hospital operator of Southeast Asia, and the International Medical University in Kuala Lumpur, and is also the majority shareholder of Acıbadem Healthcare Group, the largest Turkish private healthcare company. IHH owns 51% of the Hyderabad-based private healthcare provider Continental Hospitals Limited in India.


    6 percent stakeApollo HospitalsGlobal HospitalsIHHIHH Healthcare BerhadInternational Medical University Kuala LumpurRs 1070 crore
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok